The abstract is read at the publisher; the summary is JClub's.
Optogenetic CRISPR-dCas13 (Opto-CRISPR-TO) can acutely mislocalize endogenous Actb mRNA in mouse retina for 4 hours, redirecting β-actin and impairing vision.
- Why it matters: RNA localization controls where translation happens, but disease mechanisms are hard to test because most methods change RNA levels rather than position.
- What they did: The authors built Opto-CRISPR-TO to reposition endogenous RNAs with subcellular precision, second-scale kinetics, and reversibility, then applied it in cells and in mouse retina.
- The result: In cells, the system routes RNAs to organelles and ribonucleoprotein granules with multiplex, bidirectional control; in retina, brief Actb mislocalization remodels synapses and cell positioning and persistently impairs vision.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.